Trial intelligence / Profile preview

Remimazolam tosylate for LMA general anesthesia in middle-aged and elderly patients undergoing short urological surgery

ChiCTR2000039604Phase 4Recruiting

Sponsor
Hunan Provincial People's Hospital
Start
Nov 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of remimazolam and propofol in Not applicable as this is not a disease (4 arms), sponsored by Hunan Provincial People's Hospital. Primary endpoints: Circulatory system change, MOAA/S score and 2 more. Started Nov 2020; status: recruiting.

02

Drugs

remimazolampropofol
03

Conditions

Not applicable as this is not a disease

Beyond the preview

Go deeper on ChiCTR2000039604.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000039604.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call